Leadership and INnovation in cancer immunotherapy from Navarra (LINTERNA)
The LINTERNA project is a consortium created to promote cancer immunotherapy in Navarra. It involves public and private research centers and hospitals, a technology corporation, and a biotechnology company. Its aim is to improve cancer treatments based on immunotherapy by boosting preclinical research, discovering new biomarkers, and developing innovative drugs that reach the clinic.
- Start date: June 17, 2020
- End date: November 30, 2022
- Funder: Gobierno de Navarra. Proyectos estratégicos I+D, marco Estrategia de Especialización Inteligente S3 (reto GEMA IV)
- Nature of project: National
Need more information?
If you are interested in learning more about our research, please contact us